Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). ALLHAT Collaborative Research Group.

Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). ALLHAT Collaborative Research Group. JAMA. 2000 Apr 19; 283(15):1967-75.

View in: PubMed

subject areas

Adrenergic alpha-Antagonists
Aged
Amlodipine
Anticholesteremic Agents
Antihypertensive Agents
Cardiovascular Diseases
Chlorthalidone
Diuretics
Double-Blind Method
Doxazosin
Female
Humans
Hypertension
Lisinopril
Male
Middle Aged
Myocardial Infarction
Proportional Hazards Models
Risk
Survival Analysis

authors with profiles

Jeff D. Williamson MD, MHS